SCHEMBL9669573

SCHEMBL9669573

O=[N+]([O-])c1ccc(O)nc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 4/20 0.46
CTSB P07858 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TSHR P16473 3/20 0.44
TP53 P04637 2/20 0.44
HPGD P15428 2/20 0.44
CYP3A4 P08684 2/20 0.44
HIF1A Q16665 1/20 0.44
HSP90AA1 P07900 2/20 0.43
CTSH P09668 1/20 0.43
HSP90AB1 P08238 1/20 0.43
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MAPK1 P28482 2/20 0.41
CASP6 P55212 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
BRD4 O60885 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27227450 0.81 GPR35 (0.42) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL31189991 0.81 L3MBTL1 (0.44) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL1589012 0.81 TDP1 (0.44) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL952538 0.81 CTSB (0.47) GPR35CTSBSMN1; SMN2TSHRTP53
Bromide SCHEMBL3917241 0.79 L3MBTL1 (0.43) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL801581 0.78 CTSB (0.62) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL30271385 0.78 MAPT (0.53) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL29154637 0.78 GPR35 (0.43) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL8710611 0.78 MAPT (0.53) GPR35CTSBSMN1; SMN2TSHRTP53
SCHEMBL2128415 0.77 GPR35 (0.38) GPR35CTSBSMN1; SMN2TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110218177-B Preparation method of 2, 6-dichloro-3-nitropyridine 新发药业有限公司 2020-11-20 CN claimed
CN-110218177-A A kind of preparation method of 2,6- dichloro-3-nitropyridine 新发药业有限公司 2019-09-10 CN claimed
CN-110218177-B Preparation method of 2, 6-dichloro-3-nitropyridine 新发药业有限公司 2020-11-20 CN disclosed
CN-110218177-B Preparation method of 2, 6-dichloro-3-nitropyridine 新发药业有限公司 2020-11-20 CN disclosed
CN-110218177-A A kind of preparation method of 2,6- dichloro-3-nitropyridine 新发药业有限公司 2019-09-10 CN disclosed
CN-110218177-A A kind of preparation method of 2,6- dichloro-3-nitropyridine 新发药业有限公司 2019-09-10 CN disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed